focus -WSS

focus

author：leisure time 2025-08-12 11:28:39 - browse：81

Light hits on the portrait of George Washington on a one dollar bill. The portrait is surrounded by white and red tablets coming out of a pill bottle, as well as some coins — coverage from STAT — Adobe

WASHINGTON — Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.

When Democrats passed a law directing Medicare to negotiate drug prices, it was considered a major achievement. The new law, two decades in the making, gives Biden an accomplishment to both tout for himself and criticize Republicans for opposing — no Republicans voted to let Medicare negotiate drug prices.

Medicare price negotiation is popular with voters, as are the law’s price-inflation limits, and it includes additional, direct benefits for older adults that are easy to understand. It caps annual out-of-pocket retail-drug spending for seniors and people with disabilities, and it caps their monthly spending on insulin at $35.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Getting Alzheimer's drug Leqembi to patients can be a challenge

Wikipedia

WSS

Dogs on Prozac: What pet anti

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

MultiPlan and major insurers sued for alleged medical price

Orangutan used medicinal plant to treat wound, first time ever seen

Exact Sciences stock tumbles despite strong cancer detection sales

Dario to buy mental health app maker Twill in cash and stock deal

focus

focus

hotspot

Malaria cases in Florida and Texas: Here’s what you need to know

Dogs on Prozac: What pet anti

Guidelines to prevent youth baseball injuries need more muscle

He's a Nobel laureate. Critics say he was misleading on Covid

Sports medicine is finally prioritizing gender equality

Bird flu outbreak in cows is latest avian flu curveball

Dobbs anniversary: the lost opportunity of abortion as health care

R1 RCM gets $5.8 billion buyout offer from private equity firm

Medical leaders decry Supreme Court decision on affirmative action

Exact Sciences stock tumbles despite strong cancer detection sales

hotspot

Alabama hospital puts IVF treatments on hold

Close Medicare's dangerous gaps in addiction treatment coverage

Community Health Systems hospitals under DOJ investigation

Q&A: Jennifer Adair on making gene therapy available globally

Getting Alzheimer's drug Leqembi to patients can be a challenge

Community Health Systems hospitals under DOJ investigation

Wikipedia

explore

hotspot

focus